Skip to main content
Livermore
Livermore
ZHEN

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

CGEM holding history

Cullinan Therapeutics, Inc. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CGEM overviewAll 13F holders of CGEMFull Q2 2026 holdings

Shares (Q2 2026)
20,000
Value
$364.2K
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of CGEM by Birchview Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202620,000$364.2K0.2%00.0%UnchangedHolders
Q1 202620,000$284.2K0.2%00.0%UnchangedHolders
Q4 202520,000$207.0K0.1%00.0%UnchangedHolders
Q3 202520,000$118.6K0.1%00.0%UnchangedHolders
Q2 202520,000$150.6K0.1%00.0%UnchangedHolders
Q1 202520,000$151.4K0.1%00.0%UnchangedHolders
Q4 202420,000$243.6K0.2%00.0%UnchangedHolders
Q3 202420,000$334.8K0.3%00.0%UnchangedHolders
Q2 202420,000$348.8K0.3%−5,114−20.4%ReducedHolders
Q1 202425,114$427.9K0.3%00.0%UnchangedHolders
Q4 202325,114$255.9K0.2%00.0%UnchangedHolders
Q3 202325,114$227.3K0.2%00.0%UnchangedHolders
Q2 202325,114$270.2K0.2%00.0%UnchangedHolders
Q1 202325,114$257.0K0.2%00.0%UnchangedHolders
Q4 202225,114$265.0K0.2%00.0%UnchangedHolders
Q3 202225,114$322.0K0.2%−20,000−44.3%ReducedHolders
Q2 202245,114$578.0K0.4%00.0%UnchangedHolders
Q1 202245,114$472.0K0.3%00.0%UnchangedHolders
Q4 202145,114$696.0K0.4%00.0%UnchangedHolders
Q3 202145,114$1.02M0.7%00.0%UnchangedHolders
Q2 202145,114$1.16M0.7%−15,000−25.0%ReducedHolders
Q1 202160,114$2.50M1.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.